According to the previous researches, the effects of relieving inflammation of SPRC on cardiovascular diseases are related to the level of endogenous H2S. Therefore, we hypothesized that H2S might be an intermediate molecule between SPRC and CD24. The gene discussed is SPRR3; the disease is cardiovascular disorder.